Emverm — CareFirst (Caremark)

Initial criteria

• The infection has been confirmed by a diagnostic or laboratory test (e.g., imaging scans, scotch tape test, blood, stool, or urine test)
• Request is for mebendazole (Emverm) in a patient age ≥ 2 years for a second course of therapy (first course of therapy administered within the past year) at a dose up to 2 tablets per day for two 3-day treatments for ANY of the following infections: Ancylostoma duodenale (hookworm), Ascaris lumbricoides (roundworm), Enterobius vermicularis (pinworm), Necator americanus (hookworm), Trichuris trichiura (whipworm)

Approval duration

1 month